Cannabis Oil and Fibromyalgia: Clinical Benefit Without Blood Biomarker Change
This oral THC CBD fibromyalgia trial tested a 1:1 THC:CBD oil over 16 weeks in women with fibromyalgia. Despite no changes in peripheral blood endocannabinoid biomarkers, clinical benefits were reported. The findings suggest central nervous system…
Endocannabinoid System Identified as Therapeutic Target for Pancreatitis
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchEndocannabinoidsInflammationBiomarkersTherapeutic TargetsPancreatitisMedical Cannabis Why This Matters…
NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmacies.
A Swiss study measuring cannabis brain damage biomarkers study results in 331 regular users found no evidence of nerve damage and unexpectedly lower levels of brain injury markers. These objective biomarker findings challenge assumptions about cannabis…
Endocannabinoid Responses to Relief of Obstruction in Acute Injured Kidney: A Prospective Observational Study
The acute kidney injury endocannabinoid system plays a key role in regulating renal function during obstruction relief. This study tracks ECS responses in patients with acute renal colic. Findings highlight potential biomarkers for kidney injury and…
Scientists Zero In on CD29 Protein Marker as Key Driver of MS in New Study
The cd29 protein marker multiple sclerosis study highlights its role as a key driver of brain inflammation. This discovery could lead to improved biomarkers and targeted treatments. Researchers emphasize the importance of this protein in understanding MS…
Unlocking the Multifaceted Role of CB
CB1 receptor pharmacology research reveals the complex signaling of the endocannabinoid system. This complexity explains the challenges in developing cannabinoid therapeutics. Understanding CB1 receptor roles is key to advancing clinical outcomes.
Tecan Webinar Shares Insights on Salivary Cortisol, from Collection to Confidence
Salivary cortisol measurement cannabis protocols offer a non-invasive way to assess stress response in patients using cannabis therapeutically. This webinar highlights improved collection and analysis methods to enhance reliability. Understanding these…
Variations in p21 Protein May Explain Why Some MS Types Progress Faster
Emerging research on multiple sclerosis biomarkers highlights the role of p21 protein variations in disease progression. Understanding these biomarkers may help identify patients at higher risk for aggressive MS types. This insight supports the…
Anticancer Potential of Cannabidiol in Renal Cell Carcinoma: Serum Modulation and Preliminary Mechanistic Insights.
This study explores the anticancer potential cannabidiol renal cell carcinoma effects through serum modulation. Preliminary mechanistic insights provide a foundation for further research. The findings highlight the need for cautious interpretation in…
Endocannabinoids and Polyunsaturated Fatty Acids in Early Schizophrenia: Changes Under Antipsychotics and Treatment Response
The endocannabinoid system schizophrenia alterations are evident in early stages of the disorder. This study highlights changes in polyunsaturated fatty acids and endocannabinoids before and after antipsychotic treatment. Understanding these biochemical…